Topical Finasteride in the Treatment of Idiopathic Hirsutism
NCT ID: NCT00564252
Last Updated: 2007-11-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2006-02-28
2006-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
SINGLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
topical finasteride
0.2%topical(cream)finasteride twice a day for six months
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal serum prolactin
Exclusion Criteria
* Simultaneous use of other drugs for the treatment of hirsutism
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Firuzgar hospital affiliated to Iran University of Medical Sciences
OTHER
Iran University of Medical Sciences
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
iraj heydari, professor assistant
Role: STUDY_DIRECTOR
endocrine and metabolism centre of Iran University of Medical Sciences
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IUMS127
Identifier Type: -
Identifier Source: secondary_id
84-5-6886
Identifier Type: -
Identifier Source: org_study_id